Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phEPCAM(TACSTD1) (#RDB07367)

Promoter collection, Human EPCAM promoter

Alternative name U2694(2072)-20
Clone info. PCR amplified human EPCAM promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 47368067 to 47369577(NC_000002.12); relatively -1081 to +430, where +1 corresponds to 1 nt of NM_002354.2.
Comment PCR cloning, forward primer: CCAGCCTCCTTTCCTCTTTT; reverse primer: CTGAGCTGCGGCAAAAGTC. Entire sequence of promoter region has not been confirmed.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human tumor-associated calcium signal transducer 1 genomic DNA
Depositor|Developer DNA Bank, |
 
Remarks, protocol and/or map (pdf) RDB07367.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07367 pGL4-phEPCAM(TACSTD1) DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phEPCAM(TACSTD1) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07367).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07367_A3L2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer:
Sequence file: RDB07367_A3L2a.seq check
>07367_07367_A3L2_pGL4-4174F_A06_03.ab1
    1 ACAGGGGGCA GGAACATTTC TCTGGCCTAA CTGGCCGGTA CCTGAGCTCG CTAGCCTCGA
   61 GGATCCAGCC TCCTTTCCTC TTTTTAACTC TTACTTTTAT GATTTCTTTA GTGGATAAAA
  121 AGCTTTTAAA AAATAGGTTA CAATGATATT ACAGCTAACA AAAAATAACA TTTAAAAACA
  181 CTAAATAGTA TATATATGAA GTATTTATAA TTATTTTAAT ATTGTAATAA TATAGTGTGT
  241 TGTGATTTGA ATTCATCTGC ACGGAAATCG ATTACTGTCC TTTCTTTCTA TTTCCCTATA
  301 TTTTCTTTCC GAAGGCGTCA TCAACATTTT GGTTCTTTAA TAGTAACCAA AACCCGAAAT
  361 CATCTCGGTT CTCAGTATTT GGCTCTATGG GAACACCTTT TCTTTTCTCT CTTTTTTTTT
  421 TTTTTGAGAC GGAGTCTTGC TCCTGTCGCC CAGGCTGGAG TGTAATGGCA CGATCTCTGC
  481 TCACTGCAAC CTCAGCCTCC CCAGTAGCTG GGATTACAGG CATGCGCCAC CACGCCCGGC
  541 TAATTTTGTA TCTTTTAGTA GAGACGGCGT TCCTCCATGT TGGTCAGGCT GGTCTCGAAC
  601 TTCAAACCTC AGGTGATCCG CCCGCCTCGG CCTCCCAAAG TGCTAGGATT ACAGGCGTGA
661 GCCACCGCGC TCAGCCTGGG AACACCTTTT CTTACATCTT
//
Primer:
Sequence file: RDB07367_A3L2b.seq check
>07367_07367_A3L2_pGL4-136R_B06_06.ab1
    1 GCCTTTAACG TTTTGGCATC TGCCATGGGG GCTTTACCAA GCAGTACCGG ATTGCCAAGC
   61 TTGGCCGCCG AGGCCAGATC TTGATCTGAG CTGCGGCAAA AGTCGCCGTC GCCGCGGCAA
  121 GCAGAAGCCC GAACGCGAGG ACCTGCGGGG GCGCCATGCT GCGCGCGCGC CGAGAAGAGG
  181 GGCGCGGGAG GGGCCCGGGA CTCGCGGGAG GGCGTGCGCC GGGAGTGGGA CACGAGGAGC
  241 CGGCCGGGCA GCGCGAGGCC TGGGGCACGC GGGTCCGCGT CGGGAGGACA GCGACGAGGG
  301 GGTCCCCGGA CCGCGTCGAA GGTGCTCGCT CGCCGAAGGA CTAGCGCTCT GTGCGCGCGG
  361 CGGGGCGGAG CGCACACCTG CCCGACCTGG CGGCCCCGCC TCTCGGCCCC TTCCCGGGAC
  421 TGCTCACCTC TGGCCGCTGG TGCTCGTTGA TGAGTCACCG CCCGGGAGTT GGGGGAGTGA
  481 GTAGGCTCCC CTCCCCCAGC CCCGGCGCTG CAGTTGGGGC GCGGCCCTCT CCACAGGTGT
  541 GGGCCCGCGC GCCCCGCTCC GCCCCGCCCC AGGTGCTTCG TCTCCATGGC GGCGTTAGGG
  601 ATCTTTGGTG GCCTCCGAGG AGGTTTGAAG ATTCTGTGCT GAGACTTCCT TTTAACCGGA
661 GGAGCGCTGC TCTGAAGCCT TGAAGAATGG GGCCTGGGGG
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles